RXRX Competitors & Alternatives
Compare Recursion Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
RXRX
Main Stock$3.18
Tradestie Score
54
Market Cap
$2.23B
Revenue Growth
-0.6%
Analyst Upside
+128.0%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MNKD
Mannkind Corporation
|
$3.80
|
$1.65B | - | 51 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$38.38
|
$1.63B | - | 50 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.37
|
$1.57B | - | 51 | Compare |
|
VCEL
Vericel Corporation
|
$46.05
|
$1.56B | 108.2 | 52 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$106.02
|
$1.55B | - | 56 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$35.60
|
$1.55B | 14.5 | 59 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$32.25
|
$1.55B | - | 59 | Compare |
|
NVAX
Novavax Inc
|
$7.41
|
$1.54B | - | 56 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$14.57
|
$1.50B | 6.9 | 56 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$48.36
|
$1.50B | - | 49 | Compare |
More RXRX Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
234 stocks in this industry